The ability of antibodies to detect malignant cells and trigger diverse immune functions make them central players in the immune response and the target of many innovative therapies. The center focuses on the study of natural and therapeutic antibodies and the development of novel antibody combinations that will lead to new and more effective antibody-based therapies.

Research Groups

Dr. Rony Dahan

.
Read more about Dr. Rony Dahan

Prof. Sarel-Jacob Fleishman

.
Read more about Prof. Sarel-Jacob Fleishman

Prof. Ziv Shulman

.
Read more about Prof. Ziv Shulman

Prof. Yosef Yarden

.
Read more about Prof. Yosef Yarden